Enough of the conspiracy theories and finger pointing at someone to blame
Every time you invest on the markets you put yourself at risk, it is your decision alone.
We all know that at this stage Hemo has no revenues, therefore it has to generate its cash flow from the market
I note we are not the only pharma to raise funds recently. The market will dictate the price, it has always and always will be that way.
IN THE MEANTIME I SUGGEST WE ALL CALM DOWN AND AWAIT FOR THE SCIENCE TO DELIVER, THEN YOU WILL SEE THE TRUE VALUE THAT THE MARKET PUTS ON THE COMPANY.
GLA
Corporate news flow this year gives an indication of where the science is going,
16.02.2024 11:27 HEMO Hemogenyx shares rise on potential for CBR to treat brain diseases Alliance
16.02.2024 07:00 HEMO CBR Brain Delivery RNS
14.02.2024 10:14 HEMO Hemogenyx says CBR can be used intranasally to treat viral infections Alliance
14.02.2024 07:00 HEMO CBR Intranasal Delivery RNS
09.02.2024 10:00 HEMO IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold Alliance
02.02.2024 10:44 HEMO IN BRIEF: Hemogenyx hails US patent application progress Alliance
16.01.2024 11:13 HEMO Hemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDA Alliance
16.01.2024 07:00 HEMO Submission of Complete Response to Clinical Hold RNS
08.01.2024 10:56 HEMO Hemogenyx Pharmaceuticals completes process qualification run Alliance
08.01.2024 07:00 HEMO HEMO-CAR-T Process Qualification Run Completed RNS
I believe in the science and the ultimate success of this company
I was not tempted to sell at 5p+ earlier this month nor am i tempted to take 2p today.
THE TRUE VALUE OF THIS COMPANY IS MANY MULTIPLES OF THE RECENT SHARE PRICE
if you are prepared to stick around, you will do well.
if you are prepared to trade in and out, then good luck to you
BUT DONT UNDERESTIMATE THE VALUE OF THE SCIENCE AND WHAT THIS COMPANY IS CAPABLE OF DELIVERING IN THE FUTURE
GLA
I guess we may be few, and days like today when the share is hijacked by short term traders is hard to take.
I remember the same scenario occurred in January 2023
I also remember Vlad saying that in the end all that matters is the science
I am happy to hold and believe in his vision.
vs 74k avg volume
WHY?
...The net proceeds from the Placing will be used to facilitate progression of the Company's HEMO-CAR-T product candidate into clinical trials and to enable the Company to continue development of product candidates for the treatment of viral infections based on its Chimeric Bait Receptor ("CBR") platform.